K170300 is an FDA 510(k) clearance for the Restrata Wound Matrix. Classified as Absorbable Synthetic Wound Dressing (product code QSZ).
Submitted by Acera Surgical, Inc. (St. Louis, US). The FDA issued a Cleared decision on April 26, 2017 after a review of 85 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Acera Surgical, Inc. devices